SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: cfimx who wrote (7181)5/17/1999 8:42:00 PM
From: jeffbas  Respond to of 78470
 
Twister, you tempted me to respond once more <ggg>.

When NH was at $9 and CSE was trading at $18+ (if I recall correctly),
a 2 1/2 for 1 share deal for CSE would have had analysts falling all over themselves saying what a good deal NH got, a modest premium, synergies, a larger more stable company, at least the same if not higher projected EPS, solid balance sheet, etc. It does not change a bit if this happens when NH has doubled if you pay in stock.

However, if when NH was $9 and CSE $18+, NH offered $55 cash, the analysts would have fallen all over themselves saying what complete idiots NH was, blah, blah, blah. It only changes very slightly if this happens when NH and CSE have risen dramatically (relating to possible future NH equity offerings at better prices to reduce the debt).

Enough said.




To: cfimx who wrote (7181)5/17/1999 10:57:00 PM
From: Daniel Chisholm  Read Replies (1) | Respond to of 78470
 
[Regarding: NH paying $55 cash per CSE share vs. 2.5:1 share swap] ...it's unlikely that EITHER alternative was the prudent course.

I suppose the prudent course would be to not overpay? (whether with not-overvalued-stock or cash)

- Daniel